QUBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Quantum Computing Inc (QUBT) is not a strong buy for a beginner investor with a long-term focus at this moment. While the company operates in a high-growth industry with significant future potential, its current financial performance, technical indicators, and lack of consistent revenue generation suggest caution. The stock may be better suited for speculative investors willing to take on higher risk.
The technical indicators show a bearish trend. The MACD is negatively expanding, RSI is neutral at 31.231, and moving averages indicate a bearish setup (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 8.002), with resistance levels at R1: 9.942 and R2: 10.542. The pre-market price of $8.15 reflects a slight decline (-0.49%).
Hedge funds have significantly increased their buying activity (185.71% growth in the last quarter).
Quantum computing is projected to create $450 billion to $850 billion in global economic value by
The company operates in a high-growth sector with strong investor confidence, as evidenced by the surge in quantum computing stocks over the past year.
The company has yet to generate meaningful, consistent revenues, and faces stiff competition from major players like Amazon and Microsoft.
Financial performance shows a significant drop in net income (-141.97% YoY) and EPS (-116.67% YoY) in Q3
Technical indicators and pre-market price trends suggest a bearish sentiment in the short term.
In Q3 2025, revenue increased by 280.20% YoY to $384,000, but net income dropped significantly by -141.97% YoY to -$2,382,000. EPS also fell by -116.67% YoY to 0.01. Gross margin improved to 32.81%, up 268.24% YoY. While revenue growth is promising, profitability remains a major concern.
Analysts have mixed views. Wedbush initiated coverage with a Neutral rating and a $12 price target, citing the company's technical expertise but noting its lack of consistent revenues and competition. Lake Street lowered its price target from $24 to $16 but maintained a Buy rating, reflecting optimism about the company's revenue ramp despite broader sector challenges.
